stella
beta
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer — Stella
Recruiting
Back to Head and Neck Cancers- Squamous Cell trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Stanford University, Stanford, California
View full record on ClinicalTrials.gov